HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS (HLH)
Clinical trials for HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS (HLH) explained in plain language.
Never miss a new study
Get alerted when new HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS (HLH) trials appear
Sign up with your email to follow new studies for HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS (HLH), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Selective cell removal may tame stem cell Transplant's dangerous side effect
Disease control Not yet recruitingThis study tests whether removing a specific type of immune cell (naive T cells) from a donor's stem cell graft can prevent graft-versus-host disease (GVHD), a serious complication where donor cells attack the recipient's body. The trial enrolls people with non-malignant blood di…
Matched conditions: HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS (HLH)
Phase: PHASE2 • Sponsor: Fred Hutchinson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
Could a common vitamin a drug tame a deadly immune storm?
Disease control Not yet recruitingThis study tests a drug called all-trans retinoic acid (ATRA) as a first treatment for hemophagocytic lymphohistiocytosis (HLH), a rare but life-threatening condition where the immune system goes into overdrive. ATRA is an oral medication already used for other blood diseases and…
Matched conditions: HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS (HLH)
Phase: PHASE2, PHASE3 • Sponsor: Beijing Anzhen Hospital • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC